
Andre Elias Nel MD D.Sc, MMed
Distinguished Professor, Medicine, UCLA School of Medicine
Join to view full profile
200 Medical Plaza#365,530,420,120Los Angeles, CA 90095
Phone+1 310-825-6620
Dr. Nel is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Medical University of South Carolina College of MedicineFellowship, Allergy and Immunology, 1983 - 1985
Stellenbosch University Faculty of MedicineClass of 1975
Certifications & Licensure
CA State Medical License 1989 - 2027
SC State Medical License 1986 - 1987
American Board of Allergy and Immunology Allergy & Immunology
American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Publications & Presentations
PubMed
- 11 citations33 Unresolved Questions in Nanoscience and Nanotechnology.Chad A Mirkin, Sarah Hurst Petrosko, Natalie Artzi, Koray Aydin, Austin Biaggne
ACS Nano. 2025-09-16 - 4 citationsKRAS mRNA Spleen-Targeting Lipid Nanoparticles Synergize with Irinotecan Silicasomes to Robustly Augment the Cancer Immunity Cycle in Pancreatic Cancer.Lijia Luo, Xiang Wang, Yu-Pei Liao, Andre E Nel
Advanced Science. 2025-09-01 - 22 citationsReprogramming the Tolerogenic Immune Response Against Pancreatic Cancer Metastases by Lipid Nanoparticles Delivering a STING Agonist Plus Mutant KRAS mRNA.Xiao Xu, Xiang Wang, Yu-Pei Liao, Lijia Luo, Andre E Nel
ACS Nano. 2025-03-11
Journal Articles
- Nano-Enabled Pancreas Cancer Immunotherapy Using Immunogenic Cell Death and Reversing ImmunosuppressionAndre Nel, MD, Nature
Press Mentions
Chutes & Ladders—AltruBio Snags New CMO with Resume at Sublimity, Ardea, Amgen and AbbottSeptember 17th, 2021
UCLA Researchers Use Nanoparticles to Develop Treatment for AllergiesFebruary 7th, 2021
Hitting Target in Cancer Fight Now Easier with New Nanoparticle Platform, Scientists SayMay 5th, 2011
Grant Support
- Use of a Nano-Enabled Platform for Pancreatic Cancer ImmunotherapyUNIVERSITY OF CALIFORNIA LOS ANGELES2020–2025
- Project 2: Relating Enm Physicochemical Properties To Mechanism-Based Pulmonary TNational Institute Of Environmental Health Sciences2010–2012
- Center For Nanobiology And Predictive ToxicologyNational Institute Of Environmental Health Sciences2010–2012
- Administrative CoreNational Institute Of Environmental Health Sciences2010–2012
- Nanovalve Platform: Targeted, Controlled, Release Of Anticancer DrugsNational Cancer Institute2010–2012
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









